XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2
Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Segment Reporting Information [Line Items]        
Net sales $ 11,257 $ 10,223 $ 23,152 $ 20,679
Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 11,255 10,201 23,147 20,641
Other        
Segment Reporting Information [Line Items]        
Net sales 2 22 5 38
United States        
Segment Reporting Information [Line Items]        
Net sales 4,892 3,581 9,829 7,419
United States | Other        
Segment Reporting Information [Line Items]        
Net sales 2 15 5 25
International        
Segment Reporting Information [Line Items]        
Net sales 6,365 6,642 13,323 13,260
International | Other        
Segment Reporting Information [Line Items]        
Net sales 0 7 0 13
Established Pharmaceutical Products | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 1,223 1,180 2,370 2,250
Established Pharmaceutical Products | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 0 0 0 0
Established Pharmaceutical Products | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 1,223 1,180 2,370 2,250
Nutritionals | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 1,953 2,108 3,847 4,144
Nutritionals | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 761 873 1,438 1,709
Nutritionals | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 1,192 1,235 2,409 2,435
Diagnostics | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 4,322 3,247 9,608 7,261
Diagnostics | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 2,469 1,155 5,210 2,796
Diagnostics | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 1,853 2,092 4,398 4,465
Medical Devices | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 3,757 3,666 7,322 6,986
Medical Devices | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 1,660 1,538 3,176 2,889
Medical Devices | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 2,097 2,128 4,146 4,097
Key Emerging Markets | Established Pharmaceutical Products | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 931 915 1,833 1,736
Key Emerging Markets | Established Pharmaceutical Products | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 0 0 0 0
Key Emerging Markets | Established Pharmaceutical Products | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 931 915 1,833 1,736
Other Emerging Markets | Established Pharmaceutical Products | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 292 265 537 514
Other Emerging Markets | Established Pharmaceutical Products | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 0 0 0 0
Other Emerging Markets | Established Pharmaceutical Products | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 292 265 537 514
Pediatric Nutritionals | Nutritionals | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 925 1,093 1,772 2,159
Pediatric Nutritionals | Nutritionals | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 413 528 751 1,036
Pediatric Nutritionals | Nutritionals | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 512 565 1,021 1,123
Adult Nutritionals | Nutritionals | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 1,028 1,015 2,075 1,985
Adult Nutritionals | Nutritionals | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 348 345 687 673
Adult Nutritionals | Nutritionals | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 680 670 1,388 1,312
Core Laboratory | Diagnostics | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 1,221 1,306 2,405 2,488
Core Laboratory | Diagnostics | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 287 283 555 554
Core Laboratory | Diagnostics | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 934 1,023 1,850 1,934
Molecular | Diagnostics | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 212 290 632 737
Molecular | Diagnostics | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 71 94 243 269
Molecular | Diagnostics | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 141 196 389 468
Point of Care | Diagnostics | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 139 137 267 266
Point of Care | Diagnostics | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 101 97 192 189
Point of Care | Diagnostics | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 38 40 75 77
Rapid Diagnostics | Diagnostics | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 2,750 1,514 6,304 3,770
Rapid Diagnostics | Diagnostics | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 2,010 681 4,220 1,784
Rapid Diagnostics | Diagnostics | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 740 833 2,084 1,986
Rhythm Management | Medical Devices | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 548 567 1,072 1,086
Rhythm Management | Medical Devices | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 264 269 512 510
Rhythm Management | Medical Devices | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 284 298 560 576
Electrophysiology | Medical Devices | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 486 487 971 918
Electrophysiology | Medical Devices | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 226 209 442 388
Electrophysiology | Medical Devices | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 260 278 529 530
Heart Failure | Medical Devices | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 241 227 462 421
Heart Failure | Medical Devices | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 179 168 346 313
Heart Failure | Medical Devices | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 62 59 116 108
Vascular | Medical Devices | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 653 697 1,272 1,332
Vascular | Medical Devices | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 228 246 437 465
Vascular | Medical Devices | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 425 451 835 867
Structural Heart | Medical Devices | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 440 422 851 799
Structural Heart | Medical Devices | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 207 191 397 360
Structural Heart | Medical Devices | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 233 231 454 439
Neuromodulation | Medical Devices | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 197 210 376 394
Neuromodulation | Medical Devices | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 157 166 300 311
Neuromodulation | Medical Devices | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 40 44 76 83
Diabetes Care | Medical Devices | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 1,192 1,056 2,318 2,036
Diabetes Care | Medical Devices | United States | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 399 289 742 542
Diabetes Care | Medical Devices | International | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales $ 793 $ 767 $ 1,576 $ 1,494